Clorox sells Aplicare to Medline Industries; financial terms not disclosed
The Clorox Company announced that it has sold the Aplicare skin antisepsis business to Medline Industries, a privately-held manufacturer and distributor of health care supplies in the U.S. The transaction closed on Aug. 21. As communicated in the company's fiscal year 2017 SEC filings, Clorox had been exploring strategic alternatives for Aplicare. Clorox's Form 10-K filing on Aug. 15 reported that for fiscal year 2017, which ended June 30, 2017, the Aplicare business had $46M in net sales, representing slightly less than 1% of total company sales, and insignificant net earnings. Clorox will provide an updated fiscal year 2018 outlook during its first-quarter fiscal year 2018 earnings call on Nov. 1.